The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s ...
Goodfin, the AI wealth platform for exclusive private market investments, has released groundbreaking research led by Shilpi Nayak, Co-Founder & CTO of Goodfin, in collaboration with NYU Stern's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback